Comprehensive analysis of TRIM family ubiquitin ligases
TRIM家族泛素连接酶综合分析
基本信息
- 批准号:18390079
- 负责人:
- 金额:$ 10.57万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Ubiquitination is a versatile post-translational modification mechanism used by eukaryotic cells mainly to control protein levels through proteasome-mediated proteolysis. Ubiquitin conjugation is achieved by several enzymes that act in concert, a ubiquitin-protein ligase (E3). E3 is thought to be the component of the ubiquitin conjugation system that is most directly responsible for substrate recognition. Enzymes belonging to class E3 that have so far been identified include members of the HECT (homologous to E6-AP carboxyl terminus), RING-finger and U-box families of proteins. So far; we have published many articles about ubiquitination and oncogenesis.Tripartite motif (TRIM) proteins are characterized by the presence of a RING finger, one or two zinc-binding motifs named B-boxes and an associated coiled-coil region (BBRC357: 245, 2007; Mal Cell Biochem 307, 73, 2008; Mol Immunol 45 2045, 2008, Cancer Res, in press).We found that the putative E3 ubiquitin ligase TRIM68, which is prefe … More rentially expressed in prostate cancer cells, interacts with androgen receptor (AR) and enhances transcriptional activity of the AR in the presence of dihydrotestosterone (DHT). Overexpression of TRIM68 in prostate cancer cells caused an increase in secretion of prostate-specific antigen (PSA), one of the most reliable diagnostic markers for prostate cancer. Moreover, we showed that TRIM68 expression is significantly upregulated in human prostate cancers (Cancer Res, in press).Furthermore, we found by using yeast two-hybrid screening that TRIM32 binds to Abl-interactor 2 (Abi2), which is known as a tumor suppressor gene and a cell migration inhibitor Overexpression of TRIM32 promoted degradation of Abi2, resulting in enhancement of cell growth, transforming activity and cell motility In addition, we found that TRIM32 suppresses apoptosis induced by cis-diamminedichloroplatinum (II) (cDDP) in HEp2 cell lines. These findings suggest that TRIM32 is a novel oncogene that promotes tumor growth, metastasis and resistance to anti-cancer drugs. Less
泛素化是真核细胞主要通过蛋白酶体介导的蛋白质水解来控制蛋白质水平的一种通用的翻译后修饰机制。泛素结合是通过几种协同作用的酶实现的,即泛素-蛋白质连接酶(E3)。E3被认为是泛素缀合系统的组分,其最直接负责底物识别。迄今为止已经鉴定的属于E3类的酶包括HECT(与E6-AP羧基末端同源)、环指和U盒蛋白家族的成员。到目前为止; TRIM(Tripartite Motif)蛋白是一类具有RING指、一个或两个锌结合基序(B-boxes)和卷曲螺旋区的蛋白质(BBRC 357:245,2007; Mal Cell Biochem 307,73,2008; Mol Immunol 45 2045,2008,Cancer Res,出版中)。 ...更多信息 在前列腺癌细胞中部分表达,与雄激素受体(AR)相互作用,并在双氢睾酮(DHT)存在下增强AR的转录活性。TRIM 68在前列腺癌细胞中的过表达导致前列腺特异性抗原(PSA)分泌增加,PSA是前列腺癌最可靠的诊断标志物之一。此外,我们发现TRIM 68表达在人前列腺癌中显著上调,此外,通过使用酵母双杂交筛选,我们发现TRIM 32与已知为肿瘤抑制基因和细胞迁移抑制剂的β-interactor 2(Abi 2)结合。TRIM 32的过表达促进Abi 2的降解,导致细胞生长的增强,转化活性和细胞运动性此外,我们发现TRIM 32抑制HEp 2细胞系中顺式二氨二氯铂(II)(cDDP)诱导的细胞凋亡。这些发现表明TRIM 32是一种新的癌基因,可促进肿瘤生长、转移和对抗癌药物的耐药性。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
GdX, an X-linked ubiuitin-like modifier, is conjugated to cyclin F and regulates mitotic exit.
GdX 是一种 X 连接泛素样修饰剂,与细胞周期蛋白 F 缀合并调节有丝分裂退出。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ishida;N.;et. al
- 通讯作者:et. al
Ubiquitin-mediated regulation of coatomer protein complex, subunit epsilon by APNIP/Pirh2
APNIP/Pirh2 泛素介导的外壳蛋白复合物亚基 epsilon 调节
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Maruyama S.;et. al.
- 通讯作者:et. al.
Protection of vincristine-induced neuropathy by WldS expression and the indepen dence of the activity of Nmnatl.
WldS 表达和 Nmnatl 活性的独立性对长春新碱诱导的神经病变的保护作用。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Watanabe;M. ;et. al.
- 通讯作者:et. al.
新規ユビキチン様修飾分子GdXによるcyclin Fと細胞周期M期の制御
新型泛素样修饰分子 GdX 对细胞周期蛋白 F 和细胞周期 M 期的调节
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:石田典子;et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HATAKEYAMA Shigetsugu其他文献
HATAKEYAMA Shigetsugu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HATAKEYAMA Shigetsugu', 18)}}的其他基金
Establishment of gene expression system in Bombyx mori
家蚕基因表达系统的建立
- 批准号:
25670134 - 财政年份:2013
- 资助金额:
$ 10.57万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Comprehensive analysis of TRIM type ubiquitin ligases in cell proliferation and differentiation
TRIM型泛素连接酶对细胞增殖和分化的影响综合分析
- 批准号:
24390065 - 财政年份:2012
- 资助金额:
$ 10.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Disease models using gene expression system in Bombyx mori
使用家蚕基因表达系统的疾病模型
- 批准号:
23659144 - 财政年份:2011
- 资助金额:
$ 10.57万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Comprehensive analysis of the regulation of carcinogenesis through TRIM type ubiquitin ligases
TRIM型泛素连接酶调控癌变的综合分析
- 批准号:
21390087 - 财政年份:2009
- 资助金额:
$ 10.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Comprehensive analysis of molecules related for antigen receptor signaling
抗原受体信号传导相关分子综合分析
- 批准号:
16300093 - 财政年份:2004
- 资助金额:
$ 10.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of therapeutic method for neurodegenerative diseases by specific protein degradation system for abnormal proteinsEstablishment of therapeutic method for neurodegenerative diseases by specific protein degradation system for abnormal proteins
异常蛋白特异性蛋白降解系统治疗神经退行性疾病方法的建立通过异常蛋白特异性蛋白降解系统治疗神经退行性疾病的方法
- 批准号:
13557057 - 财政年份:2001
- 资助金额:
$ 10.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
proteasome抑制剂诱导恶性增殖白血病细胞凋亡的分子机制
- 批准号:30100223
- 批准年份:2001
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
Ubiquitin-proteasome系统在多发性肌炎/皮肌炎发病机制中的作用
- 批准号:30170885
- 批准年份:2001
- 资助金额:16.0 万元
- 项目类别:面上项目
相似海外基金
Proteasome homeostasis and substrate prioritization
蛋白酶体稳态和底物优先顺序
- 批准号:
10623563 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Control of the programmed cell death machinery by the ubiquitin-proteasome system in neurons
神经元中泛素蛋白酶体系统对程序性细胞死亡机制的控制
- 批准号:
2884939 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Studentship
How the proteasome works: resolving a critical new level of regulation
蛋白酶体如何工作:解决关键的新监管水平
- 批准号:
BB/W016672/1 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Research Grant
Alleviating age-related memory impairment through proteasome stimulation
通过蛋白酶体刺激减轻与年龄相关的记忆障碍
- 批准号:
10811380 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Proteasome Inhibitor-Loaded Antibody Drug Conjugates with High Drug Loading For Targeted Treatment of Triple Negative Breast Cancers
负载蛋白酶体抑制剂的高载药量抗体药物偶联物用于三阴性乳腺癌的靶向治疗
- 批准号:
10822628 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance
劫持疟原虫泛素蛋白酶体系统以击败耐药性
- 批准号:
10719157 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Mechanism and dynamics of the nuclear localization of the human 26S proteasome (B11*)
人类 26S 蛋白酶体 (B11*) 核定位的机制和动力学
- 批准号:
524414553 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Collaborative Research Centres
Estrogenic regulation of the hippocampal ubiquitin-proteasome system and its role in memory and structural plastcity
海马泛素-蛋白酶体系统的雌激素调节及其在记忆和结构可塑性中的作用
- 批准号:
10735271 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
The Role of the Neuronal Membrane Proteasome in the Peripheral Nervous System and Pain Sensation
神经膜蛋白酶体在周围神经系统和痛觉中的作用
- 批准号:
10751515 - 财政年份:2023
- 资助金额:
$ 10.57万 - 项目类别:
Overcoming proteasome impairment with small molecules
用小分子克服蛋白酶体损伤
- 批准号:
10427952 - 财政年份:2022
- 资助金额:
$ 10.57万 - 项目类别:














{{item.name}}会员




